Academic Journal

Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.

Bibliographic Details
Title: Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.
Authors: Olde Nordkamp, LRA, Pepplinkhuizen, S, Ghani, A, Boersma, LVA, Kuschyk, J, El-Chami, MF, Behr, ER, Brouwer, TF, Kääb, S, Mittal, S, Quast, A-FBE, van der Stuijt, W, Smeding, L, de Veld, JA, Tijssen, JGP, Bijsterveld, NR, Richter, S, Brouwer, MA, de Groot, JR, Kooiman, KM, Lambiase, PD, Neuzil, P, Vernooy, K, Alings, M, Betts, TR, Bracke, FALE, Burke, MC, de Jong, JSSG, Wright, DJ, Jansen, WPJ, Whinnett, ZI, Nordbeck, P, Knaut, M, Philbert, BT, van Opstal, JM, Chicos, AB, Allaart, CP, Borger van der Burg, AE, Dizon, JM, Miller, MA, Nemirovsky, D, Surber, R, Upadhyay, GA, Weiss, R, de Weger, A, Wilde, AAM, Knops, RE, PRAETORIAN Investigators
Publisher Information: American Heart Association
Publication Year: 2024
Collection: St George's University of London: Repository
Description: BACKGROUND: Inappropriate therapy (IAT) is an undesirable side effect of implantable cardiac defibrillator (ICD) therapy. Early studies with the subcutaneous ICD (S-ICD) showed relatively high inappropriate shock (IAS) rates. The PRAETORIAN (Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy) trial demonstrated that the S-ICD is noninferior to the transvenous ICD (TV-ICD) with regard to the combined end point of IAS and complications. This secondary analyses evaluates all IAT in the PRAETORIAN trial. METHODS: This international, multicenter trial randomized 849 patients with an indication for ICD therapy between S-ICD (n=426) and TV-ICD therapy (n=423). ICD programming was mandated by protocol. All analysis were performed in the modified intention-to-treat population. RESULTS: In both groups 42 patients experienced IAT (48-month Kaplan-Meier estimated cumulative incidence, 9.9% and 10.1%, respectively; hazard ratio (HR), 0.99 [95% CI, 0.65-1.52]; P=0.97). There was no significant difference in patients experiencing IAS between both groups (P=0.14). In the S-ICD group, 81 IAT episodes with 124 IAS and 1 inappropriate antitachycardia pacing occurred versus 89 IAT episodes with 130 IAS and 124 inappropriate antitachycardia pacing in the TV-ICD group. IAT episodes were most frequently caused by supraventricular tachycardias in the TV-ICD group (n=83/89) versus cardiac oversensing in the S-ICD group (n=40/81). In the TV-ICD group, a baseline heart rate >80 bpm (HR, 1.99 [95% CI, 1.05-3.76]; P=0.03), a history of atrial fibrillation (HR, 2.66 [95% CI, 1.41-5.02]; P=0.003), and smoking (HR, 2.46 [95% CI, 1.31-4.09]; P=0.005) were independent predictors for IAT. A QRS duration >120 ms was an independent predictor for IAT caused by cardiac oversensing in the S-ICD group (HR, 3.13 [95% CI, 1.34-7.31]; P=0.008). Post-IAS interventions significantly reduced IAS recurrence in both groups (P=0.046). CONCLUSIONS: There was no significant difference in IAT and ...
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
ISSN: 1941-3084
Relation: https://openaccess.sgul.ac.uk/id/eprint/116988/1/olde-nordkamp-et-al-2024-inappropriate-therapy-and-shock-rates-between-the-subcutaneous-and-transvenous-implantable.pdf; https://openaccess.sgul.ac.uk/id/eprint/116988/6/circae-2024-012836-t-s01.pdf; Olde Nordkamp, LRA; Pepplinkhuizen, S; Ghani, A; Boersma, LVA; Kuschyk, J; El-Chami, MF; Behr, ER; Brouwer, TF; Kääb, S; Mittal, S; et al. Olde Nordkamp, LRA; Pepplinkhuizen, S; Ghani, A; Boersma, LVA; Kuschyk, J; El-Chami, MF; Behr, ER; Brouwer, TF; Kääb, S; Mittal, S; Quast, A-FBE; van der Stuijt, W; Smeding, L; de Veld, JA; Tijssen, JGP; Bijsterveld, NR; Richter, S; Brouwer, MA; de Groot, JR; Kooiman, KM; Lambiase, PD; Neuzil, P; Vernooy, K; Alings, M; Betts, TR; Bracke, FALE; Burke, MC; de Jong, JSSG; Wright, DJ; Jansen, WPJ; Whinnett, ZI; Nordbeck, P; Knaut, M; Philbert, BT; van Opstal, JM; Chicos, AB; Allaart, CP; Borger van der Burg, AE; Dizon, JM; Miller, MA; Nemirovsky, D; Surber, R; Upadhyay, GA; Weiss, R; de Weger, A; Wilde, AAM; Knops, RE; PRAETORIAN Investigators (2024) Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial. Circ Arrhythm Electrophysiol, 17 (12). e012836. ISSN 1941-3084 https://doi.org/10.1161/CIRCEP.124.012836 SGUL Authors: Behr, Elijah Raphael
DOI: 10.1161/CIRCEP.124.012836
Availability: https://openaccess.sgul.ac.uk/id/eprint/116988/
https://doi.org/10.1161/CIRCEP.124.012836
Rights: cc_by_nc_nd_4
Accession Number: edsbas.319C4F0A
Database: BASE
Description
ISSN:19413084
DOI:10.1161/CIRCEP.124.012836